Marker Therapeutics Management
Management criteria checks 2/4
Marker Therapeutics' CEO is Juan Vera, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is $585.25K, comprised of 68.2% salary and 31.8% bonuses, including company stock and options. directly owns 2.99% of the company’s shares, worth €795.39K. The average tenure of the management team and the board of directors is 1.5 years and 6.3 years respectively.
Key information
Juan Vera
Chief executive officer
US$585.3k
Total compensation
| CEO salary percentage | 68.2% |
| CEO tenure | 1.5yrs |
| CEO ownership | 3.0% |
| Management average tenure | 1.5yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$10m |
| Jun 30 2024 | n/a | n/a | -US$10m |
| Mar 31 2024 | n/a | n/a | -US$12m |
| Dec 31 2023 | US$585k | US$399k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$14m |
| Jun 30 2023 | n/a | n/a | -US$17m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$582k | US$380k | -US$20m |
Compensation vs Market: Juan's total compensation ($USD585.25K) is about average for companies of similar size in the German market ($USD471.14K).
Compensation vs Earnings: Juan's compensation has increased whilst the company is unprofitable.
CEO
Juan Vera (44 yo)
1.5yrs
Tenure
US$585,251
Compensation
Dr. Juan F. Vera, MD, serves as Chief Executive Officer and President at Marker Therapeutics, Inc. since May 1, 2023 and serves as its Secretary and Treasurer. He has held various positions at the Center f...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 1.5yrs | US$585.25k | 2.99% € 795.4k | |
| Director of Administration | 8.2yrs | no data | no data | |
| Director of Corporate Operations & External Communications | less than a year | no data | no data | |
| Vice President of Human Resources | 1.8yrs | no data | no data | |
| Chief Medical Officer | 1.5yrs | no data | no data | |
| Head of Clinical Operations | less than a year | no data | no data | |
| Head of Regulatory Affairs | less than a year | no data | no data | |
| Senior Director of Molecular Biology & Virology | no data | no data | no data |
1.5yrs
Average Tenure
44yo
Average Age
Experienced Management: GX1's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.1yrs | US$585.25k | 2.99% € 795.4k | |
| Independent Director | 5.3yrs | US$76.14k | 0.033% € 8.8k | |
| Member of Scientific Advisory Board | 6.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.8yrs | no data | no data | |
| Independent Chairman | 6.1yrs | US$124.04k | 0.041% € 11.0k | |
| Member of Scientific Advisory Board | 6.5yrs | no data | no data | |
| Independent Director | 6.1yrs | US$63.44k | 8.76% € 2.3m | |
| Member of Scientific Advisory Board | 6.8yrs | no data | no data | |
| Independent Director | 2.9yrs | US$79.67k | 0.0017% € 446.2 |
6.3yrs
Average Tenure
62yo
Average Age
Experienced Board: GX1's board of directors are considered experienced (6.3 years average tenure).